NHS National Branded Interim - 1 June 2026
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £1,346,663,020 (£1,615,995,624 inc. VAT) |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | East of England, North East, North West, East Midlands, West Midlands, South East, South West, Yorkshire and the Humber, London |
| Deadline | 6 Mar 2026 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-05fbbc |
Awards (51)
This procurement was awarded to 51 suppliers. Values shown are per-award; the notice total is £1,346,663,020.
| Supplier | Value | Date | Status |
|---|---|---|---|
| ACCORD-UK LTD shared | £529,090,780 | 9 Apr 2026 | active |
| ASCEND LABORATORIES (UK) LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| ASPIRE PHARMA LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| ASTRAZENECA UK LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| AVENTIS PHARMA LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| CAMURUS AB shared | £529,090,780 | 9 Apr 2026 | active |
| CIPLA (EU) LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| CONSILIENT HEALTH (UK) LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| CST PHARMA LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| DAY LEWIS MEDICAL LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| ESSENTIAL PHARMA LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| ESTEVE PHARMACEUTICALS LTD shared | £529,090,780 | 9 Apr 2026 | active |
| EUMEDICA PHARMA LTD shared | £529,090,780 | 9 Apr 2026 | active |
| FLEXIPHARM AUSTRADING LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| FLYNN PHARMA LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| GLENMARK PHARMACEUTICALS EUROPE LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| GRUNENTHAL LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| JANSSEN-CILAG LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| LOGIXX PHARMA LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| LUPIN HEALTHCARE (UK) LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| MARTINDALE PHARMA (MACARTHYS LABORATORIES LIMITED) shared | £529,090,780 | 9 Apr 2026 | active |
| MEDAC PHARMA LLP shared | £529,090,780 | 9 Apr 2026 | active |
| MERCK SHARP & DOHME (UK) LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| MERCURY PHARMACEUTICALS LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| MORNINGSIDE PHARMACEUTICALS LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| MSN LABORATORIES EUROPE LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| NAPP PHARMACEUTICALS LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| NEURAXPHARM UK LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| NORDIC PHARMA LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| NORGINE PHARMACEUTICALS LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| NOVARTIS PHARMACEUTICALS UK LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| ORPHALAN UK LTD shared | £529,090,780 | 9 Apr 2026 | active |
| PFIZER LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| RENASCIENCE PHARMA LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| ROSEMONT PHARMACEUTICALS LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| SANTEN UK LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| SELECTIVE SUPPLIES LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| SERB LTD shared | £529,090,780 | 9 Apr 2026 | active |
| STIRLING ANGLIAN PHARMACEUTICALS LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| SUN PHARMA UK LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| SWEDISH ORPHAN BIOVITRUM LTD shared | £529,090,780 | 9 Apr 2026 | active |
| SYNCHRONY (CNX THERAPEUTICS LIMITED) shared | £529,090,780 | 9 Apr 2026 | active |
| SYRI LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| TAKEDA UK LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| TEVA UK LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| THEA PHARMACEUTICALS LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| THORNTON & ROSS LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| UNICORN PHARMACEUTICALS LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| VIATRIS UK HEALTHCARE LIMITED (MYLAN) shared | £529,090,780 | 9 Apr 2026 | active |
| ZENTIVA PHARMA UK LIMITED shared | £529,090,780 | 9 Apr 2026 | active |
| ZYDUS PHARMACEUTICALS UK LTD shared | £529,090,780 | 9 Apr 2026 | active |
description
Provision of an NHS National Branded Interim - 1 June 2026
01/06/2026 - 30/04/2028 23 Months with an option or options to extend at the discretion of the authority up to a maximum of 25 months
documents
- https://www.find-tender.service.gov.uk/Notice/009548-2026 , tenderNotice
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-11367 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-11368 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-11369 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-11370 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-11371 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-11372 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-11373 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-11374 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-11375 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-11376 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-11377 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-11378 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-11379 , biddingDocuments
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
6 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 22 Dec 2025 | Preliminary market engagement (UK2) | Procurement Act 2023 | 085478-2025 |
| 23 Dec 2025 | Preliminary market engagement (UK2) | Procurement Act 2023 | 085750-2025 |
| 29 Dec 2025 | Preliminary market engagement (UK2) | Procurement Act 2023 | 086256-2025 |
| 3 Feb 2026 | Tender notice (UK4) | Procurement Act 2023 | 009548-2026 |
| 16 Apr 2026 | Contract award (UK6) | Procurement Act 2023 | 034841-2026 |
| 22 May 2026 | Contract details (UK7) | Procurement Act 2023 | 047944-2026 |
more from NHS England
- Exam Support Packages for EoE GP Registrars · £72,673 · 24 Jul 2026
- Refer a Patient - Adult ECMO 2026/27 · £99,362 · 23 Jul 2026
- Higher Specialist Scientist Training Programme (HSST) · £42,186,231 · 23 Jul 2026
- Imaging National Lecture Series · £400,000 · 22 Jul 2026
- NHS National Framework for Lenvatinib · £35,833,000 · 22 Jul 2026
- The Practice Education Facilitator role in Return to Practice · £20,000 · 22 Jul 2026
- Pharmacy Technician Clinical Skills Development · £300,000 · 22 Jul 2026
- NHS National Framework for Ferric Carboxymaltose injection · £62,633,000 · 21 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.